Revolution Medicines, Inc. is a precision oncology company focusing on developing targeted therapies for RAS-addicted cancers. Their pipeline includes RAS(ON) inhibitors and companion inhibitors for combination treatments. The company's key candidates are in various stages of clinical trials.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay